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1. CONCEPTUAL FEATURES OF THE RESEARCH 
 
The actuality of the topic. Bruxism is a widely spread condition; in general about 85-90% 
of the population clench their teeth during certain periods of their life, in 5% of these people 
clenching transforms into a clinical disorder [3]. The average prevalence of bruxism is about 20% 
of the population, affecting approximately 14-18% of children, 13% of adolescents, 5-6% of adults 
and about 3% of people over 60 [9, 10, 11]. 
There are various theories and hypotheses regarding the etiology and pathogenesis of 
bruxism: occlusal, muscular, psycho-behavioral, humoral, genetic and others [1, 9, 11, 19]. The 
high incidence of sleep bruxism is explained by the influence of psycho-emotional factors with a 
predominant role of emotional stress [7, 9, 20]. It has been shown that emotional stress and anxiety 
are important factors for the appearance/maintenance of bruxism. Some authors consider occlusal 
disorders to be the primary etiological factor, however clinically it has been proven that bruxism 
can be found in patients with normal occlusal indices; moreover, there are patients with significant 
occlusal disorders without any signs of bruxism [13, 20]. 
In recent years there were discovered neurogenic interactions between masticatory muscles 
and different brain centers; it is supposed that there may exist a “bruxism generator” at brainstem 
level [9, 10], this fact increasing the significance of neurophysiological investigations of this 
disorder. In many cases, sleep bruxism is latent (subclinical) without being identifiable by means 
of dental methods [20]. In subclinical variants of sleep bruxism, disease outbreak is already at 
stages when various complications (dental abrasion, root fractures, etc.) occur. Based on this, it 
becomes imperative to develop methods for diagnosing bruxism at the initial stages by applying 
pathogenetically based neurophysiological methods. 
Clinical manifestations and management of bruxism depend on the action of multiple 
etiological and pathogenic factors, among which the daily cofactors of bruxism (such as alcohol, 
caffeine, nicotine, etc.) play an important role [2, 4, 11, 14]. The role of these cofactors from a 
diagnostic, clinical and therapeutic aspect is partially deciphered. A slightly less studied aspect is 
the clinical manifestation of bruxism at different periods of life. 
In recent years, there has been achieved great success in the treatment of sleep bruxism and 
its complications [9, 10, 15]. Currently, there persists the issue of creating individualized programs 
for the complex treatment of primary sleep bruxism with the inclusion of dental treatment and 
daily self-help methods (relaxation techniques, meditation, massage etc.) [1, 5, 6, 8, 20]. 
The hypothesis of the study. Clinical manifestations of primary sleep bruxism depend on 
the patients’age, the presence/intensity of intrinsic factors (tooth damage, temporomandibular joint 
dysfunction etc.) and extrinsic factors (psycho-emotional disorders, professional activity, daily 
cofactors of bruxism – alcohol, caffeine, nicotine etc.), the study of which will allow to elucidate 
some new pathogenetic aspects of primary bruxism, to optimize the diagnosis with the 
identification of the predominant clinical-neurophysiological patterns, will allow to create 
individualized treatment programs and self-help recommendations in a day-to-day setting, which 
can contribute to the enhancement of the complex treatment. 
The purpose of the research. Optimization of the diagnosis and treatment of primary sleep 
bruxism based on identifying of the clinico-neurophysiological particularities of bruxism 
manifestation in relation to the patients’ age and the influence of the daily cofactors, creating 
pathogenetically-based self-help methods. 
The objectives of the research. 
1. The analysis of the clinical particularities, ultrasonographic indices of masticatory muscles and 
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of the autonomous regulation processes in stomatognathic system in patients with primary sleep 
bruxism based on their age and the influence of the daily cofactors of bruxism. 
2. The study of the peculiarities of manifestation of primary sleep bruxism based on the prevalence 
of nasal or oral diurnal respiration. 
3. The elaboration of pathogenetically-based daily self-help methods in patients with primary sleep 
bruxism by applying respiratory-individualized splints and by stimulation of the reflexogenic 
zones of the stomatognathic system. 
4. The increase the treatment efficacy of the primary sleep bruxism based on the combination of 
different types of splints and self-help methods. 
Methodology of the scientific research. The methodology of the scientific research was 
based on the concept of diagnosis and treatment of sleep bruxism following European and 
American dental guidelines [3, 9]. The research was based on the concepts regarding sleep bruxism 
that include the role of the patients’ age, the influence of psycho-emotional factors and of the 
bruxism cofactors (alcohol, caffeine, nicotine, etc.) [2, 7, 9, 10, 14]. The researches were based on 
the multi-systemic and multifactorial concept of dental disorders correction in patients with 
bruxism [9]. The investigation and interpretation of the results was accomplished based on the 
concept that refers to the complex interrelation of bruxism and emotional stress [17]. 
Scientific novelty and originality. 
• Scientific originality relies on the analysis of clinico-neurophysiological changes in patients with 
primary sleep bruxism based on their age, with the identification of clinical particularities, occlusal 
reflexes, autonomous regulation processes in stomatognathic system and structural-
ultrasonographic indices of the masticatory muscles. 
• Novel is the identification of peculiarities regarding the activity of the stomatognathic system in 
patients with primary sleep bruxism under the influence of psychoactive substances (alcohol, 
caffeine, nicotine) and with a various level of patients’ physical activity. 
• Novel are the obtained results that reflect the thermo-vasomotor-metabolic changes of the 
masticatory muscles in the patients with primary sleep bruxism based on the patients’ age, the 
action of the psychoactive substances (alcohol, nicotine, caffeine) and the level patients’ physical 
activity. 
• For the first time there has been demonstrated the influence of the psychoactive substances 
(alcohol, caffeine, nicotine) and of physical activity upon the processes of autonomous regulation 
in the stomatognathic system in patients with primary sleep bruxism. 
• Original is the systematization of the main components of the disorders in patients with sleep 
bruxism (psychogenic, reflective-occlusal, myogenous, arthrogenic, dento-periodontal, respiratory, 
autonomous, algic), which form the predominant clinical-neurophysiological patterns. 
• For the first time there have been identified the particularities of the occlusal reflex associated 
with the efficacy of applying myorelaxing splints in patients with primary sleep bruxism. 
• Novel is the obtained data regarding the scientific argumentation of the possibilities of correcting 
bruxism-associated disorders by means of applying the splint-respiratory treatment and by 
stimulation of the auricular reflexogenic zones of the stomatognathic system. 
The main scientific results submitted for the defense. 
1. In patients with primary sleep bruxism, there are present various variants of the clinical 
neuro-neurophysiological patterns, the structure and the expressivity of which depend on the age 
and the action of daily cofactors of bruxism. 
2. Based on the complex diagnosis (clinical, psychological, neurophysiological, 
electrophysiological, radiological) there are evidenced clinico-neurophysiological particularities 
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of the primary sleep bruxism, which make the differentiated treatment possible. 
3. Clinical manifestations of primary sleep bruxism may be associated with diurnal oral 
breathing syndrome, requiring an individualized treatment. 
4. The indication and application of myorelaxing splints based on clinical-neurophysiological 
indices substantially increases their effectiveness. 
5. Splint-respiratory treatment and the reflex-bruxism-regulating self-help method in patients 
with primary sleep bruxism diminishes the frequency and intensity of nocturnal episodes of 
bruxism, improves the psycho-emotional condition and the autonomous regulation processes in 
the stomatognathic system. 
The implementation of the scientific results. The scientific results were implemented in 
the research process and clinical activity at the Municipal Stomatological Center (Chisinau), 
Republican Stomatological Policlinic, "Megalux Dent" Dental Clinic. 
The approval of the scientific results. The results were presented at national and 
international scientific forums: XVIII Congress of The Association of Stomatologists from the 
Republic of Moldova (Chisinau, 2016); Scientific Conference – Days of the State University of 
Medicine and Pharmacy "Nicolae Testemitanu" (Chisinau, 2016); National symposium with 
international participation NANO-2016 (Chisinau, 2016); Congress of physiologists from CIS 
countries (Soci, 2016); V Congress of Biochemists from Russia (Soci-Dagomys, 2016); VIII 
International Congress of the Romanian Dental Association for Education (Iasi, 2016); XX 
International Congress of UNAS (Bucharest, 2016). The endorsement of the thesis title took place 
during the meeting of the Scientific Council of USMF "Nicolae Testemitanu" – minutes no. 4/6.2 
from July 4th 2016. The positive opinion of the Research Ethics Committee for the study was 
obtained: minutes no. 37 of 04.05.2016. The results were approved at the meeting of the 
Department of Therapeutic Dentistry of USMF "Nicolae Testemitanu" from 19.12.2018, Scientific 
Seminar on Dentistry Profile from 20.03.2019. The research was conducted at the Department of 
Therapeutic Dentistry of USMF "Nicolae Testemitanu", Dental Clinic "Fala Dental "and at the 
University Clinic “Neuronova”. 
Key words: primary sleep bruxism, clinical neurophysiological pattern, self-help, co-factors 
of bruxism. 
 
2. MATERIAL AND RESEARCH METHODS 
2.1. General characteristics of the researched group (sample volume, study design, 
inclusion/exclusion criteria) 
In the study there were enrolled patients aged 18-50: the group aged under 35 included 70 
patients, between 35-50 – 30 patients; women in total – 68, under 35 years – 50 women, between 
35-50 –18; men in total – 32, under 35 years – 20, between 35-50 – 12. We have analyzed the 
action of the co-factors of bruxism (alcohol, caffeine, nicotine, hypodynamic activity) and the 
effectiveness of complex treatment with the use of splints and self-help methods. 
Criteria for inclusion in the research: Positive clinical diagnosis of primary sleep bruxism, 
confirmed by objective recording of the nocturnal episodes; total dentition or partial edentulism 
up to 1-3 teeth; age of patients between 18-50 years; presence of patient’s consent for participation 
in research; cooperating patients. 
Criteria for exclusion from the research: age does not fit the established limits; other clinical 
forms of bruxism (central nervous system disorders, epilepsy, parkinsonism, etc.); the presence of 
anomalies and inflammatory signs in the stomatognathic system; presence of signs of organic 
damage (bioelectric activity recorded via electromyography (EMG) in the state of relaxation is 
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less than 30 mcV); various acute and chronic diseases during periods of aggravation, parasitosis; 
alcoholism, drug addiction, toxicomania, mental illnesses; treatment with psychotropic medicines, 
anticonvulsants, miorelaxants; lack of patients’ consent for participation in the research; non-
cooperating patients. 
 
 
Figure 21. The study design regarding the patients with primary sleep bruxism based on the 
patients’ age and the action of co-factors of bruxism. 
 
2.2. Clinical and psychometric methods 
We have applied specialized questionnaires and tests [9, 10, 18]: bruxism questionnaire, 
Fonseca questionnaire, multifactorial questionnaire of bruxism-associated pain, sleep quality 
questionnaire, palpation of the masticatory muscles, evaluation of dental abrasion, evaluation of 
the emotional stress level using the visual analogue scale (VAS). In order to analyze the type of 
Patients under 35 years (n = 70)/Patients over 35 years (n = 30) 
The influence of daily co-factors – stress, alcohol, caffeine, nicotine, physical activity (n= 100) 
Clinical-neuropsychological 
investigations 
Paraclinical/neurophysiological investigations 
Clinical manifestations 
(questionnaires/tests) 
Temporomandibular joint 
(questionnaires/tests) 
Stress, psycho-emotional 
state 
(questionnaires/tests) 
Quantitative indices of 
bruxism (Sleep Guard 
SG5) 
Autonomous evoked 
potentials 
(NeuroMVPMicro) 
Ultrasonography 
(Philips EnVisorC) 
EMG, oclussal 
reflex 
(NeuroMVPMicro) 
Indices of physical 
activity (S Health, 
Samsung) 
Computerized 
tomography 
(Gendex, BRD) 
Deciphering some of the pathogenetic aspects of primary sleep bruxism, optimization of bruxism 
diagnosis with the identification of the predominant clinico-neurophysiological pattern based on the 
patients’ age and the influence of the bruxism co-factors, developing daily self-help methods. 
Quantitative and 
qualitative indices of 
nocturnal sleep 
Daily respiratory 
indices (2 mirrors test) 
Infrared 
thermography (Irtis 
2000) 
Primary sleep bruxism – conventional dental diagnosis (n = 100) 
Primary sleep bruxism – clinical-neurophysiological diagnosis (n = 100) 
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breathing (nasal/oral/mixed) and the hypoxic resistance we have applied the “2 mirrors test” and 
the Shtange test. 
2.3. Electrophysiological and neurophysiological methods 
The surface electromyography recordings of the masticatory muscles, the determination of 
the masseter inhibitory reflex (MIR), and the recording of the jaw clenching sympathetic skin 
responses (jc.SSR) were performed by means of the diagnostic complex Neuro-MVP Micro 
(Neurosoft). In order to determine the Total Number of Clenches (TNC) and Total Clench Time 
(TCT) we have applied the portable Sleep Guard SG5 (Hollistic Inc., USA). 
2.4. Imaging methods 
We have used computerized tomography (Gendex, Germany), ultrasonography (USG) 
(Envisor C, Philips) of the stomatognathic system [12] and infrared thermography (IRTIS 2000, 
Russia) [22]. 
2.5. The treatment of primary sleep bruxism and the self-help methods 
Patients received dental treatment based on indications (abrasions, fissures, etc.). We have 
applied the Reflex-Bruxism-Regulating (RBR) method, which is based on the stimulation of the 
auricular reflexogenic zones of the stomatognathic system. Myorelaxing splints were used by 50 
patients with sleep bruxism (SB) as monotherapy and by 50 patients in combination with the 
reflex-bruxism-regulating method. Splint-respiratory treatment was applied to 13 SB patients with 
predominant oral respiration and to 30 patients with predominant nasal breathing. The respiratory 
training was used in order to diminish the psycho-autonomous disorders [21] and to adapt the 
stomatognathic system to the applied splints. 
2.6. Mathematical and statistical processing of the research material 
The results obtained were processed with the help of the software package for statistical 
analysis Statistics for Windows, Release 11.0 StatSoft, Inc. (US). We have determined the 
arithmetic mean and the standard error (SE). We have used the Student test to compare the averages 
of a specific feature between two groups. In order to determine the degree and the type of 
correlation between the studied values we have used the Pearson and Spearmen correlation 
coefficients. We have calculated the efficacy coefficient in order to assess the effectiveness of the 
applied treatment, by using: 
β = 1 −
(𝐹−𝑁)
(𝐼−𝑁)
× 100%         (1) 
where: I – the value of the parameters before the treatment; F – final parameters after the treatment; 
N – parameters in healthy people. 
 
3. THE CLINICAL-NEUROPHYSIOLOGICAL PATTERN OF PRIMARY SLEEP 
BRUXISM BASED ON THE AGE OF THE PATIENTS AND THE INFLUENCE OF 
DAILY COFACTORS 
3.1. Manifestations of bruxism based on the patients’ age 
Based on the fact that increased stress reactivity contributes to the occurrence of several 
disorders of SB, people with SB have a much higher level of stress activity, and in most cases they 
refer to A type personalities [7, 11, 17]. We have studied the level of emotional stress and the 
professions of the patients vs. the patients’ age. In healthy people, highly stressful professions 
constituted up to 30% of the cases; the expression of VAS-stress – 3.80 ± 0.35 pt. In patients with 
SB of various age (18-50 years, n = 100), highly stressful professions amounted to 24% of the 
cases; VAS-Stress – 5.71 ± 0.31 pt. In patients with SB, aged under 35, highly stressful professions 
made up to 21.4% of the cases; VAS-stress – 5.99 ± 0.28 pt. In patients with SB, aged over 35, 
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highly stressful professions amounted to 30% of the cases; VAS-stress – 5.43 ± 0.35 pt. Sleep 
quality in patients with SB, aged under 35 (statistical significance in comparison to the data 
regarding older patients): normal sleep – 20 patients (28.6%), p>0.05; borderline disorders – 38 
patients (54.3%), p<0.01; pathological sleep – 12 patients (17.1%), p<0.001. The quality of sleep 
in patients with SB, aged over 35, based on self-assessment, is the following (statistical 
significance in comparison to the data regarding younger patients): normal sleep – 4 patients 
(13.3%), p>0.05; borderline disorders – 8 patients (26.7%), p<0.01; pathological sleep – 18 
patients (60.0%), p<0.001. In patients, aged under 30, clinical manifestations of SB are more 
pronounced in comparison with older patients: bruxism questionnaire – p<0.05; pain questionnaire 
– p>0.05; Fonseca questionnaire – p<0.05, gradient of masseter muscle thickness (GMT) – 
p<0.001. 
The pain pattern in patients aged under 35 can be characterized as psycho-emotional-
myogenous circadian pain and in older patients as psycho-emotional-myogenous-arthrogenic 
circadian pain (figure 31). 
 
Figure 31. The intensity of bruxism-associated pain in patients with sleep bruxism in 
correlation with age. 
Note: vertically – symptoms intensity (pt.); horizontally – bruxism-associated pain scales (factors): I – 
arthrogenic; II – myogenous; III – loco-regional referral; IV – autonomous; V- psycho-emotional; 
VI – circadian; VII – pain intensity; VIII – pain duration. Statistically significant differences: SB, 
patients under 35 years vs. patients over 35 years – (* – p < 0,05; ** – p < 0,01). 
 
TNC indices in healthy individuals were 3.4 ± 0.95 units (un.); in patients with SB (n = 100) 
– 50.4 ± 5.96 un; in patients with SB, aged under 35 – 65.4 ± 5.26 un.; in patients with SB, aged 
over 35 – 35.4 ± 6.44 un.; TCT indices in healthy individuals were 3.6 ± 0.68 seconds; in patients 
with SB (n = 100) – 86.5 ± 7.93 s; in patients with SB, aged under 35 – 110.5 ± 8.22 s; in patients 
with SB, aged over 35 – 61.5 ± 6.91 s. The analysis of the occlusal reflex indices (MIR) revealed 
that the SP2 (occlusal reflex phase 1) variants – SP2 – normal inhibition, and SP2 – partial 
inhibition are informative for the differentiation of occlusal disorders among healthy individuals 
and patients with SB in general, regardless of age (p<0.001), however, for the differentiation of 
occlusal disorders between patients with SB under and over 35 years old, the SP2 component – no 
inhibition is more informative (p<0.05, Figure 32). 
Normally, in healthy individuals in 100% of cases in the postural position of the mandible 
(state of relaxation), based on the data acquired via infrared thermography, the activity of the 
thermo-vasomotor-metabolic processes in the anterior temporal muscle (AT) predominates the one 
from the masseter muscle (MM), AT>MM). 
In patients with SB, aged under 35 in 11.4% of cases, there can be observed a predomination 
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of the thermo-vasomotor-metabolic activity of the masseter muscles (AT<MM), indicating the 
discoordination of these processes, in comparison to the healthy individuals, and in individuals 
aged over 35, in already 23.3% of cases the thermo-vasomotor-metabolic processes predominate 
in the masseter muscle (AT<MM). 
 
Figure 32. Frequency of EMG indices of the occlusal reflex (MIR) in healthy individuals 
and patients with sleep bruxism. 
Note: vertically – the frequency of SP2 variants; statistically significant differences (* – p < 0,05; *** – p < 
0,001; x – p > 0,05). 
 
The obtained results show that the sympathetic autonomous response in the standardized 
jaw-clenching conditions is informative in the detection of sympathetic autonomous disorders in 
the masticatory muscles: the amplitude of the autonomous-sympathetic response at a standardized 
jaw clenching (jc.SSR-S, A2) in patients aged under 35 – 2.52 ± 0.17 mV, in individuals aged over 
35 years – 3.11 ± 0.21 mV (p<0.05); the restoration period for the evoked autonomous-sympathetic 
potential (jc.SSR-S, T) in patients under 35 – 9.3 ± 0.35 s, in individuals aged over 35 years – 10.5 
± 0.43 s (p<0.05 ). These indices can be used with the aim of differentiating the patients with SB 
from the healthy individuals and for determining the severity of the autonomous disorders based 
on the age of patients with SB. 
3.2. Daily cofactors of the primary sleep bruxism 
Stressogenic professions in alcohol-abstinent patients constitute 26.3%, in patients who 
consume 1-3 un. of alcohol the presence of stressful professions is 22.0%, and at the consumption 
of more than 3 un. of alcohol – 27.3%. The expression of VAS-stress in abstainers – 5.2 ± 0.34 pt; 
alcohol consumption of 1-3 un. – 5.6 ± 0.39 points (pt); alcohol consumption of more than 3 un. – 
6.3 ± 0.36 pt. The duration of nighttime sleep in patients with SB based on the alcohol consumption 
is of 7.8 ± 0.56 hours in abstainers; 7.2 ± 0.48 hours at a consumption of 1-3 un. of alcohol and of 
6.4 ± 0.43 hours at a consumption of more than 3 un. Consumption of 1-3 un. of alcohol leads to 
the occurrence of pathological sleep in 9 out of 59 patients (15.3%), but excessive alcohol 
consumption (more than 3 un. in 24 hours) is associated in 81.8% of cases with the presence of 
pathological sleep (18 patients out of 22 investigated, p<0.001 vs. abstainers). Clinical expression 
of SB is much higher in people with excessive alcohol consumption (Table 31). 
***
***
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x
x
*
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TNC vs. alcohol consumption in patients with primary sleep bruxism: abstainers – 38.4 ± 
3.75 un., alcohol consumption 1-3 un. – 47.7 ± 7.02 un., alcohol consumption of more than 3 un. 
– 65.1 ± 3.96 un. TCT vs. alcohol consumption in patients with SB: abstainers – 58.75 ± 7.38 s, 
alcohol consumption 1-3 un. (n = 59) – 84.9 ± 8.15 s, alcohol consumption of more than 3 un. – 
120.43 ± 8.46 s. Out of 19 abstinent patients, normal inhibition of SP2 was found in 9 individuals 
(47.4%), pathological inhibition – in 10 patients (52.6%). In patients with an alcohol consumption 
of 1-3 un. of alcohol, an SP2 with normal inhibition was observed in 7 individuals (11.9%, p<0.01 
in comparison to abstainers) and in 52 individuals (88.1%, p<0.01), there was a various degree of 
pathological SP2 values (partial inhibition/no inhibition). The most significant changes for SP2 
were observed at the consumption of more than 3 un. of alcohol: normal inhibition is present in 
only 3 patients (13.6%, p<0.05) and pathological MIR was observed in 19 patients (86.4% p<0.05). 
 
Table 31. Age of patients, clinical manifestations of bruxism and ultrasonographic indices 
of the masseter muscle vs. alcohol consumption per 24 hours. 
Indices 
Alcohol consumption 
Abstainers 
(n=19) 
1-3 un. 
(n=59) 
>3 un. 
(n=22) 
Age, years 38.7 ± 1.22 32.6 ± 1.16** 28.3 ± 0.82*** 
Bruxism questionnaire, pt. 3.1 ± 0.18 3.6 ± 0.25 7.8 ± 0.22*** 
Pain questionnaire, pt. 5.20 ± 0.42 5.08 ± 0.39 3.85 ± 0.31** 
Fonseca questionnaire , pt. 42.34 ± 3.58 53.49 ± 3.91 60.23 ± 4.28** 
USG, GMT index, % 26.7 ± 0.59 28.4 ± 0.48 30.3 ± 0.51*** 
USG, echogenicity, un. 1.10 ± 0.11 1.38 ± 0.10 1.49 ± 0.11* 
Dental wear, un. 1.40 ± 0.21 1.90 ± 0.18 2.50 ± 0.16*** 
Note: statistical differences vs. abstainers (* – p < 0,05; ** – p < 0,01; *** – p < 0,001); there are indicated 
the arithmetic mean and standard error (M ± SE). 
 
In patients with higher alcohol consumption (>3 un.), there is also a statistically significant 
increase in the sympathetic activity in the stomatognathic system. jc.SSR-S, A2 mV: alcohol >3 
un. vs. abstainers – 2.2 ± 0.19 (p<0.001); jcSSR-S, T, s: alcohol >3 un. vs. abstainers – 10.4 ± 0.34 
(p<0.05). According to the infrared thermography data, simultaneously with the increase of the 
amount of the consumed alcohol, there is an increase in the thermo-vasomotor-metabolic disorders 
in AT/MM muscles, with the most serious disorders being observed in patients that consume 
excessive amounts of alcohol (more than 3 un./24 hours) in comparison to healthy individuals 
(p<0.001). 
Frequency of highly stressful professions vs. caffeine consumption in patients with SB: 
abstainers (n = 32) – 15.6%, consumption of 1-3 cups (n = 38) – 10.5%, consumption of 4-6 cups 
(n = 19) – 6%, consumption of more than 6 cups (n = 11) – 81.8%. VAS-stress in abstainers was 
4.8 ± 0.31 pt., in patients who consumed 1-3 cups – 5.2 ± 0.33 pt.; in patients who consumed 4-6 
cups – 6.1 ± 0 , 32-pt., in patients who consume more than 6 cups – 6.7 ± 0.23 pt. Statistical 
differences in comparison to abstainers were observed in the group of patients who consume 4-6 
cups in 24 hours (p<0.01) and in the group with a consumption of more than 6 cups (p<0.001). 
According to self-assessment, pathological sleep in caffeine-abstinent patients was found in 12.5% 
of cases; minimal caffeine consumption (1-3 cups) leads to pathological sleep in 13.2% of cases; 
moderate consumption (4-6 cups of coffee) is associated with the presence of pathological sleep 
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in 63.2% of cases, and excessive caffeine consumption is manifested by the disturbance of sleep 
quality in 81.8% of cases. The duration of night sleep tends to decrease, however the differences 
between the studied groups are insignificant: abstainers – 7.6 ± 0.58 hours; 1-3 cups of coffee – 
7.5 ± 0.53 hours; 4-6 cups – 6.8 ± 0.51 hours; more than 6 cups – 6.2 ± 0.45 hours. The clinical 
manifestations of SB in correlation with the consumed caffeine doses have certain peculiarities 
with the intensification of disorders at caffeine overuse (Table 32). 
TNC indices vs. caffeine consumption in patients with SB: abstainers (n = 32) – 38.7 ± 7.29 
un., consumption of 1-3 cups (n = 38) – 50.1 ± 7.14 un., consumption of 4-6 cups (n = 19) – 50.8 
± 6.88 un., consumption of more than 6 cups (n = 11) – 60.9 ± 6.63 un. TNC indices vs. 
consumption of caffeine in patients with primary sleep bruxism: abstainers – 60.37 ± 8.63 s, 
consumption of 1-3 cups – 88.67 ± 7.91 s, consumption of 4-6 cups – 86.61 ± 8.55 s, consumption 
of more than 6 cups – 111.45 ± 6.89 s. In individuals who do not consume caffeine there can be 
observed a SP2 with normal inhibition in 16 patients (50%) and with a pathological inhibition – 
16 patients (50 %). Consumption of 1 to 3 cups of coffee per day leads to pathological disorders 
of the SP2 activity in 29 patients (76.3%, p<0.05 in comparison with abstainers), consumption of 
4-6 cups causes pathological disorders of SP2 inhibition in 16 patients (89.5%, p<0.01) and 
excessive consumption (more than 6 cups) results in the appearance of pathological variants of 
SP2 in all patients (100%, p<0.001) in this group. 
 
Table 32. Patients' age, clinical manifestations of bruxism, and ultrasonography indices of 
masseter muscle vs. caffeine consumption per 24 hours in patients 
Indices 
Caffeine consumption 
Abstainers 
(n = 32) 
1-3 cups 
(n = 38) 
4-6 cups 
(n = 19) 
>6 cups 
(n = 11) 
Age, years 37.1 ± 1.42 34.4 ± 0.98 32.6 ± 0.92* 28.5 ± 1.12*** 
Bruxism questionnaire, pt. 3.9 ± 0.25 4.8 ± 0.28* 4.9 ± 0.33* 5.9 ± 0.31*** 
Pain questionnaire, pt. 4.11 ± 0.51 4.40 ± 0.43 4.43 ± 0.42 5.90 ± 0.33* 
Fonseca questionnaire, pt. 41.32 ± 3.66 48.39 ± 4.01 
56.43 ± 
3.96** 
61.94 ± 4.15*** 
USG, GMT index, % 27.8 ± 0.48 28.0 ± 0.49 28.7 ± 0.51 29.0 ± 0.52 
USG, echogenicity, un. 1.28 ± 0.10 1.30 ± 0.09 1.39 ± 0.10 1.43 ± 0.11 
Dental wear, un. 1.71 ± 0.24 1.79 ± 0.23 2.12 ± 0.18 2.13 ± 0.15 
Note: statistical differences vs. abstainers (*- p<0.05; ***- p<0.001); there are indicated the arithmetic 
mean and standard error (M ± SE). 
 
In our investigations for the first time, it was observed that excessive caffeine consumption 
(more than 6 cups per day) leads to disturbances of the sympathetic autonomous activity in the 
stomatognathic system: jc.SSR-H, A2, mV: 4.6 ± 0.38 vs. abstainers 3.1 ± 0.41 (p<0.05); jc.SSR-
S, A2 mV: 3.5 ± 0.38 vs. abstainers 2.15 ± 0.26 (p<0.01). Unlike other psychoactive factors 
(nicotine, alcohol) under the influence of caffeine, there is no evidence of increased conduction 
time (jc.SSR, T, s) in autonomous regulation processes, the fact that confirms the stimulating 
effects of caffeine. The analysis of thermo-vasomotor-metabolic indices of AT/MM muscles 
according to the infrared thermography data has revealed pathological disorders in individuals that 
consume more than 6 cups in 24 hours. 
Frequency of stressogenic professions vs. nicotine consumption is the following: 10.0% in 
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abstainers, 12.0% in smokers of 1-5 cigarettes and 40.0% in smokers of more than 5 cigarettes. 
Indices of emotional stress expression vs. nicotine consumption in patients with SB is as follows: 
abstinent patients – VAS-stress 5.1 ± 0.29 points; smokers of 1-5 cigarettes – 6.1 ± 0.33 pt.; 
smokers of more than 5 cigarettes – 5.9 ± 0.21 pt. Statistical differences (p<0.05) compared to 
abstainers was evidenced in smokers of 1-5 and more than 5 cigarettes in 24 hours. According to 
the self-assessment of sleep in 23.3% of cases, there is a pathological sleep in non-smoking patients; 
smoking of 1-5 cigarettes per day leads to the occurrence of pathological sleep in 36.0% of cases, 
and excessive smoking (more than 5 cigarettes) is associated with pathological sleep in 31.1% of 
cases. Sleep duration is as follows: abstainers- 7.2 ± 0.56 hours; smokers of 1-5 cigarettes – 7.6 ± 
0.48 hours; smokers of more than 5 cigarettes in 24 hours – 6.5 ± 0.53 hours. Differences between 
groups are statistically insignificant (p>0.05). 
There has been observed an important clinical particularity in smokers – the consumption of 
more than 5 cigarettes/24 hours leads to the increase in subjectively assessed disorders (bruxism 
questionnaire) and the predominance of temporomandibular joint dysfunction (Fonseca 
questionnaire) (Table 33). In abstinent individuals, TNC values were equal to 41.4 ± 6.45 un., and 
TCT – 63.34 ± 6.83 s. In patients with SB who smoke 1-5 cigarettes (n = 25) the TNC had values 
of 43, 8 ± 6.0 un., and TCT – 77.96 ± 8.15 s; in patients with SB who smoke more than 5 cigarettes 
(n = 45) the TNC has values of 63.0 ± 5.37 un. and TCT – 117.18 ± 7.76 s. In non-smokers, there 
were observed normal values of SP2 component of occlusal reflex in 10 patients (33.3%) and 
pathologic SP2 was found in 20 patients (66.7%); in smokers of 1-5 cigarettes pathological SP2 
has been observed in 18 patients (72%) and in smokers of more than 5 cigarettes pathological SP2 
is present in 35 patients (77.8%). 
 
Table 33. Patients’ age, clinical manifestations of bruxism, and ultrasonography indices of 
masseter muscle vs. nicotine intake per 24 hours in patients. 
Indices 
Nicotine intake 
Abstainers 
(n = 30) 
1-5 cigarettes 
(n = 25) 
>5 cigarettes 
(n = 45) 
Age, years 37.2 ± 1.24 27.0 ± 1.21*** 35.4 ± 1.35 
Bruxism questionnaire, pt. 3.7 ± 0.24 4.4 ± 0.31 6.5 ± 0.22*** 
Pain questionnaire, pt. 4.28 ± 0.44 4.6 ± 0.41 5.25 ± 0.38 
Fonseca questionnaire, pt. 49.08 ± 3.85 45.62 ± 4.01 61.36 ± 4.42* 
USG, GGM indices, % 27.5 ± 0.57 28.4 ± 0.54 29.3 ± 0.48* 
USG, echogenicity, un. 1.12 ± 0.11 1.46 ± 0.12* 1.47 ± 0.10* 
Dental wear, un. 1.62 ± 0.25 1.84 ± 0.21 2.35 ± 0.15** 
Note: statistical differences vs. abstainers (* – p<0.05; ** – p<0.01; *** – p<0.001); there are indicated the 
arithmetic mean and standard error (M ± SE). 
 
In patients who smoked more than 5 cigarettes per day there is observed the statistically 
significant increase of the period jc.SSR-S, T, s: 11.0 ± 0.32 vs. abstainers – 9.5 ± 0.31 (p<0.01). 
With the increase of the number of cigarettes, there is observed an increase of the thermo-
vasomotor-metabolic disorders, with the most serious disorders in smokers of more than 5 
cigarettes (p<0.001). 
Highly stressogenic professions occur in 25.0% of cases in patients with normal motor 
activity (5.18 ± 0.25 km/24 hours) and in 23.5% of cases in patients with reduced motor activity 
14 
(2.50 ± 0.11 km/24 hours). The emotional stress (VAS – stress) indices are characterized by the 
following values: normal motor activity – 5.2 ± 0.31 pt.; hypodynamic activity 6.2 ± 0.32 pt. 
(p<0.05). In patients with normal physical activity the presence of pathological sleep is observed 
in 6.3% of cases and in patients with hypodynamic activity, pathological sleep is present in 41.2% 
of cases (p<0.001). Sleep duration tends to decrease in patients with hypodynamic activity: normal 
activity – 7.7 ± 0.51 hours; hypodynamic activity – 6.4 ± 0.48 hours. Patients with hypodynamic 
activity have pronounced clinical manifestations of SB at a subjective level (bruxism questionnaire 
etc.) in association with pathological changes in the masticatory muscles (pathological ecogenity, 
thickness of the muscles) (Table 34). 
The TNC in individuals with normal motor activity is equal to 34.8 ± 7.88 un., and in those 
with reduced motor activity 66.3 ± 6.94 un. TCT in individuals with normal motor activity is 55.33 
± 7.79 s and in people with reduced motor activity 122.65 ± 8.32 s. Normal physical activity is 
associated in 20 patients (62.5%) with MIR indices within the norm limits, and in 12 patients 
(37.5%) the SP2 inhibition processes are deregulated. Reduced physical activity is associated with 
MIR indices within the normal range in 7 patients (10.3%) and with varying degree of deviation 
in 61 patients (89.7%, p<0.001 in comparison with abstainers). Autonomous indices are very 
informative in patients with SB and hypodynamic activity: the amplitude of the autonomous-
sympathetic response to a normal jaw clenching (jc.SSR-H, A2, mV) 4.4 ± 0.31 vs. normal motor 
activity 3.2 ± 0.36 (p<0.05), jSSSR-S, A2, mV 3.2 ± 0.25 vs. normal motor activity 2.4 ± 0.24 
(p<0.05). 
 
Table 34. Patients’ age, clinical manifestations of bruxism and ultrasonography indices of 
masseter muscle vs. motor activity per 24 hours in patients. 
Indices 
Motor activity 
Normal 
(n = 32) 
Reduced (hypodynamic 
activity) (n = 68) 
Age, years 29.6 ± 1.12 37.0 ± 1.34*** 
Bruxism questionnaire, pt. 3.6 ± 0.29 6.1 ± 0.33*** 
Pain questionnaire, pt. 3.95 ± 0.36 5.47 ± 0.45* 
Fonseca questionnaire, pt. 43.85 ± 3.49 60.19 ± 4.52* 
USG, GGM indices, % 27.65 ± 0.59 29.15 ± 0.43* 
USG, echogenicity, un. 1.20 ± 0.11 1.50 ± 0.09* 
Dental wear, un. 1.75 ± 0.16 2.12 ± 0.22 
Note: statistical differences: hypodynamic activity vs. normal motor activity (* – p<0.05;*** – p<0.001); 
there are indicated the arithmetic mean and standard error (M ± SE). 
 
The thermo-vasomotor-metabolic ratio of AT/MM muscles according to infrared 
thermography data in patients with SB and hypodynamic activity is essentially deregulated 
(p<0.001) in comparison with indices in healthy individuals. 
 
4. DAILY SELF-HELP TECHNIQUES IN THE COMPLEX TREATMENT OF 
PRIMARY SLEEP BRUXISM 
4.1. The effectiveness of the reflex-bruxism-regulating method in correlation with the level 
of emotional stress 
In patients with SB and signs of emotional stress (VAS-stress >5 pt.) under the influence of 
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the RBR method there were observed improvements of VAS-stress (p<0.001), sleep quality 
(p<0.01) and autonomous regulating processes (p<0.05). Correction efficacy (β) for TNC – 56.0%, 
TCT – 65.0%. In patients with SB with no signs of emotional stress (VAS-stress <5 pt.) the 
application of the RBR method caused positive tendencies (p>0.05) for VAS-stress, night sleep 
quality and autonomous regulation processes. The correction efficacy (β) for TNC – 63.0% and 
TCT – 69.0%. 
In healthy individuals with signs of emotional stress (VAS-stress >5 pt.) the application of 
the RBR method caused positive changes in the psycho-emotional, autonomous state and TNC, 
TCT indices, but in healthy individuals without signs of emotional stress (VAS-stress <5 pt.), the 
application of the RBR method led to a harmonization of psycho-emotional, autonomous and 
motor functions (TNC, TCT). 
Based on the obtained results, it can be assumed that under the influence of the RBR method 
the transformation of the stress-pathogenic bruxism into the stress-sanogenic one occurs. 
4.2. The effectiveness of the reflex-bruxism-regulating method in combination with 
myorelaxing splints 
The analysis of the results in patients with SB who used splints and did not apply RBR 
method revealed that in the cases of normal inhibition of SP2, the indices of masticatory muscle 
hyperactivity (TNC, TCT) show a tendency towards normalization, however the values do not 
reach the statistically significant threshold even after 6 months (p >0.05) (Table 41). The analysis 
of autonomous indices (jc.SSR-H, A2 and jc.SSR-H, T) revealed a slightly pronounced change in 
all the periods of investigation. It should be noted that the level of emotional stress tended to 
diminish, however the values did not reach the threshold of statistical significance. Another picture 
can be observed in patients with SB who used splints with SP2 variants partial inhibition or no 
inhibition – there is a statistically significant decrease (p<0.05) of TNC and TCT values. At the 
same time, there is observed a statistically significant decrease of the indices of the sympathetic 
autonomous regulation in the stomatognathic system (jc.SSR-H, A2), the stress level diminishes 
statistically respectively (p<0.05) (Table 41). 
Table 41. The comparative analysis of the efficacy of myorelaxing splints in patients with 
primary sleep bruxism in correlation with occlusive reflex indices (MIR). 
MIR Indices 
Monitoring period 
β, % Pretreatmen
t 
Treatment 
1st month 3 months 6 months 
Normal 
inhibition 
(n = 13) 
TNC, un. 49.6 ± 5.92 46.4 ± 5.81 39.7 ± 5.38 34.6 ± 6.35 32.0 
TCT, s. 85.2 ± 7.84 79.6 ± 7.23 69.9 ± 6.91 64.5 ± 6.94 25.0 
jc.SSR-H,A2, mV 3.64 ± 0.21 3.61 ± 0.32 3.91 ± 0.19# 3.71 ± 0.23 5.0 
jc.SSR-H, T, s. 10.30 ± 0.38 10.10 ± 0.34 9.92 ± 0.37 9.71 ± 0.33 18.0 
VAS-stress, pt. 5.7 ± 0.38 5.5 ± 0.39 5.2 ± 0.51 5.1 ± 0.46 32.0 
Partial 
inhibition/n
o inhibition 
(n = 37) 
TNC, un. 47.5 ± 5.78 42.3 ± 5.52 35.6 ± 5.49 30.9 ± 5.83* 38.0 
TCT, s. 82.3 ± 7.90 74.6 ± 7.46 63.4 ± 7.92# 60.2 ± 6.9*## 28.0 
jc.SSR-H, A2, mV 4.05 ± 0.28 3.78 ± 0.31 3.38 ± 0.23## 3.32 ± 0.22*# 37.0 
jc.SSR-H, T, s. 10.11 ± 0.33 9.82 ± 0.31 9.71 ± 0.38 9.55 ± 0.35 81.0 
VAS-stress, pt. 5.4 ± 0.33 4.8 ± 0.39 4.3 ± 0.31* 4.4 ± 0.37* 63.0 
Note: statistical differences: vs. period of pre-treatment (* – p<0.05); vs. the use of splints in combination 
with RBR method (# – p<0.05, ## – p<0.01); there are indicated the arithmetic mean and standard 
error (M ± SE). 
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Under the influence of myorelaxing splints in 6 months there occur positive tendencies in 
the thermo-vasomotor-metabolic activity of AT/MM muscles assessed by means of infrared 
thermography method. Another pattern is manifested in patients with SB who used myorelaxing 
splints altogether with RBR method (Table 42). An essential fact is that the therapeutic effect is 
much more pronounced in patients with partial inhibition/no inhibition of SP2 compared to 
patients with SP2 inhibition within the normal limits. These peculiarities are manifested at the 
motor, psycho-emotional and autonomous level. The results denote that the SP2 – partial 
inhibition /no inhibition is an important criterion that determines the effectiveness of application 
of splints. 
Table 42. The efficacy of myorelaxing splints in combination with the reflex-bruxism-
regulating method in patients with primary sleep bruxism in correlation with occlusal 
reflex indices (MIR). 
MIR Indices 
Monitoring period 
β,% Pre-
treatment 
Treatment 
1st month 3 months 6 months 
Normal 
inhibition 
(n = 14) 
TNC, un. 51.2 ± 6.02 46.8 ± 5.86 35.8 ± 6.22 32.6 ± 7.13 39.0 
TCT, s. 87.8 ± 8.13 77.4 ± 7.64 58.8 ± 7.92* 56.9 ± 9.56* 37.0 
jc.SSR-H,A2, mV 3.91 ± 0.28 3.51 ± 0.25 3.10 ± 0.29*# 2.90 ± 0.39* 56.0 
jc.SSR-H, T, s. 10.61 ± 0.41 10.12 ± 0.34 9.71 ± 0.31 9.64 ± 0.32 20.0 
VAS-stress, pt. 5.5 ± 0.35 5.2 ± 0.38 4.1 ± 0.33** 4.0 ± 0.41** 88.0 
Partial 
inhibition/n
o inhibition 
(n = 36) 
TNC, un. 53.3 ± 6.39 44.8 ± 6.24 26.3 ± 5.63** 23.4± 5.75*** 60.0 
TCT, s. 90.7 ± 7.96 68.9 ± 7.53* 38.1±6.48***# 31.8±6.93***## 68.0 
jc.SSR-H,A2, mV 3.51 ± 0.24 2.97 ± 0.28 2.43±0.2***## 2.38 ±0.41***# 80.0 
jc.SSR-H, T, s. 10.58 ± 0.31 10.16 ± 0.36 9.62 ± 0.30* 9.41 ± 0.42* 50.0 
VAS-stress, pt. 5.8 ± 0.37 5.2 ± 0.41 4.0 ± 0.39*** 4.1 ± 0.28*** 85.0 
Note: treatment vs. pre-treatment (* – p<0.05; ** – p<0.01; *** – p<0.001); vs. the use of splints 
without RBR method (# – p<0.05; ## – p<0.01); there are indicated arithmetic mean and 
standard error (M ± SE). 
 
The analysis of vascular-metabolic activity of AT/MM muscles under the influence of splint 
reflex-bruxism-regulating treatment revealed an improvement of these indices by 7.2% in patients 
with normal SP2 and 8.3% in patients with pathologic SP2. 
The obtained results give the possibility to recommend splints especially in patients with 
SP2 – partial inhibition/no inhibition. This criterion is an objective one; it reflects the pathogenetic 
mechanisms of SB with differentiation of patients in accordance with occlusal reflex 
manifestations. 
 
4.3. The effectiveness of Splint-Respiratory Treatment in patients with primary sleep 
bruxism in accordance with the type of daytime breathing 
Splint-Respiratory Treatment (SRT) in patients with oral treatment (n=13) improved 
respiration in 76.9% of cases, out of which 46.2% of cases constituted the pattern of nasal 
respiration. In patients with SB and nasal respiration (n=30) the application of SRT did not modify 
the predominant type of respiration. In patients with SB and nasal respiration, the efficiency of 
correction (β) under the influence of SRT was 29.0% for TNC and 36.0% for TCT; in patients with 
SB and oral respiration syndrome (ORS) the efficiency of SRT is 40.0% for TNC and 52.0% for 
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TCT. SRT in patients with nasal respiration improves thermo-vasomotor-metabolic rapport of 
AT/MM muscles in 6.7% of cases, but in patients with ORS in 38.5% of cases. The analysis of 
modifications of VAS-stress indices, sleep quality and autonomous adjusting (jc.SSR-H) in the 
stomatognathic system in patients with nasal respiration and ORS under the influence of SRT 
evidenced positive tendencies of these processes. We distinguished the particularities of the 
manifestation of oral symptoms (there is indicated the frequency of manifestation and statistical 
differences respectively-patients with nasal respiration vs. oral respiration): xerostomia 10.0/53.8% 
(p<0.01), marginal gingivitis 3.3%/30.8% (p<0.05), glossoptosis 0/38.5% (p<0.01), tongue 
ulceration 0/30.8% (p<0.05). 
 
Figure 42. Algorithm of combining the dental treatment and self-help methods in patients 
with primary sleep bruxism. 
 
As a result of the accomplished investigations, we have developed an algorithm combining 
the dental treatment and the self-help methods in patients with SB, which is presented in Figure 
42.
PRIMARY SLEEP BRUXISM 
Dental diagnosis of primary sleep bruxism: clenching/grinding/gnashing; centric/eccentric; low/medium/high intensity; 
episodic/frequent/constant frequency; phasic/tonic/mixed episodes 
 
Complex dental treatment (abrasions/fractures, dental mobility/hypersensitivity, exostosis, hypertrophy/fatigability of 
masticatory muscles, limited mandibular movements etc.) 
 
Self-help methods (dentist’s recommendations) 
Controlling bruxism 
cofactors 
Daytime/Evening Nighttime 
Alcohol 
<3 un. 
Oral 
hygiene 
Myorelaxing 
splints 
Sleep 
hygiene 
Caffeine 
<6 cups 
Stress/ 
anxiety 
reduction 
Splint-
respiratory 
training Individualized 
splints 
Nicotine intake 
≤5 cigarettes 
Harmonization 
of 
psychomotor 
processes 
Reflex-
bruxism-
regulating 
method 
Sleep Guard 
(monitoring/ 
biofeedback) 
Physical 
activity>2,5km/24 ore 
Iatrogenic bruxism 
remedies/conditions 
Positive dynamics/improvement 
Negative dynamics/aggravation 
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GENERAL CONCLUSIONS 
1. In the process of diagnosis, treatment and monitoring of primary sleep bruxism, the particularities 
of predominant clinical-neurophysiological patterns are assessed (psychogenic, neurogenic-reflectory, 
myogenous, arthrogenic, dental-periodontal, autonomous-sympathetic, algic) manifestations of which 
depend on excessive/ moderate caffeine consume in 57.0%/11.0%, nicotine in 25.0%/45.0%, alcohol in 
59.0%/22.0% and the presence of hypodynamic activity in 68.0% of cases. 
2. The expression of primary sleep bruxism manifestations is dependent on the age of the patients: 
manifestations in younger individuals (18-35 years) are characterized by more severe disorders of the 
nocturnal episode of bruxism (p<0,05), pathological activity of masticatory muscles according to infrared 
thermography, myogenic-spastic and more pronounced reflectory-occlusal disorders (p<0,001); 
manifestations in elderly patients (35-50 years) are characterized by predominance of local and diffuse 
myogenic structural disturbances (p<0,01), more pronounced arthrogenic pain (p<0,05), autonomous-
sympathetic dysfunction in the stomatognathic system (p<0,05), more severe quantitative (p<0,05)  and 
qualitative (p<0,001) disorders of nighttime sleep. 
3. In patients with primary sleep bruxism excessive consumption of psychoactive substances and 
hypodynamic activity have a negative influence on sleep bruxism manifestations with the increase of 
severity of disorders in the following order: nocturnal episode and associated clinical disorders – 
nicotine<hypodynamic activity<caffeine<alcohol; pathological occlusal reflex – 
nicotine<alcohol<hypodynamic activity<caffeine; the pathological activity of masticatory muscles 
according to infrared thermography – hypodynamic activity<nicotine<caffeine<alcohol; thickness and 
pathological ecogenity of masseter muscle – caffeine<nicotine = hypodynamic activity<alcohol; 
autonomous-sympathetic disorders in the stomatognathic system – hypodynamic activity<nicotine = 
caffeine<alcohol; night sleep disorder – nicotine<hypodynamic activity<alcohol = caffeine; degree of 
dental wear – hypodynamic activity = caffeine<nicotine<alcohol. 
4. In patients with primary sleep bruxism, the values of the autonomous-sympathetic response at 
habitual and standardized jaw clenching, the indices of infrared thermography of the masticatory muscles 
reflect the degree of impairment of the autonomous regulation processes in the stomatognathic system and 
the severity of the bruxism in correlation with the patients’ age and the action of the cofactors of bruxism 
(alcohol, nicotine, caffeine, hypodynamic activity). 
5. The elaborated reflex-bruxism-regulating method diminishes the emotional stress and autonomous-
sympathetic disorders in the stomatognathic system (p<0,05), the severity of the nocturnal episodes of 
bruxism (p<0,001), improves the sleep (p<0,001), it is simple in accomplishment, does not provoke side 
effects or complications. The combination of splints with the reflex-bruxism-regulating method greatly 
enhances the effectiveness of the treatment. The efficacy of nocturnal splints in patients with primary sleep 
bruxism depends on the variant of expression of the occlusal reflex: there is lesser efficacy in the normal 
inhibition variant; and there is greater efficacy in partial inhibition/no inhibition (p<0,05). 
6. In patients with primary sleep bruxism in 13% of cases, there was present normal diurnal oral 
breathing syndrome that is accompanied with more frequent and more serious manifestations of nocturnal 
episodes, more pronounced pathological activity of masticatory muscles according to infrared 
thermography, sleep quality diminishing, more frequent presence of xerostomia, marginal gingivitis, 
glossoptosis and ulceration of the tongue. In patients with primary sleep bruxism and oral breathing 
syndrome it is effective to apply splint-respiratory therapy. 
7. The use of myorelaxing splints, splint-respiratory treatment and the reflex-bruxism-regulating 
method contribute to an increased control over the manifestations of primary sleep bruxism with the 
transformation of the stress-pathogenic bruxism into stress-sanogenic bruxism. 
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AT – anterior temporal muscle; 
EMG – electromyography; 
GGM – the gradient of the masseter muscle thickness; 
j.SSR-H, A2 –amplitude of the autonomous-sympathetic response to normal jaw clenching; 
jc.SSR, T – period of restoration of evoked autonomous-sympathetic potential; 
jc.SSR-S, A2 –amplitude of the autonomous-sympathetic response to standardized jaw clenching; 
MIR – occlusal reflex; 
MM – the masseter muscle; 
OBS – oral breathing syndrome; 
pt. – points; 
RBR – reflex-bruxism-regulating method; 
SB – sleep bruxism; 
SRT – splint-respiratory treatment; 
TCT – total clench time; 
TNC – total number of clenches; 
un. – units; 
USG – ultrasonography; 
VAS – Visual Analogue Scale. 
